146 related articles for article (PubMed ID: 10451795)
1. Clearance and renal extraction of technetium-99m-L,L-ethylenedicysteine, I-131-ortho-iodohippurate and I-125-iothalamate in pigs.
Nielsen SS; Poulsen EU; Marqversen J; Nielsen LE; Bacher T; Rehling M
Clin Physiol; 1999 Jul; 19(4):338-43. PubMed ID: 10451795
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-MAG3 kinetics in the normal pig. A comparison to 131I-OIH and 125I-iothalamate after single injection and during continuous infusion.
Rehling M; Frøkiaer J; Poulsen EU; Marqversen J; Nielsen BV; Bacher T
Clin Physiol; 1995 Jan; 15(1):57-71. PubMed ID: 7712693
[TBL] [Abstract][Full Text] [Related]
3. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
4. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH.
Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C
J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m ethylene dicysteine: a new renal tubular function agent.
Kabasakal L
Eur J Nucl Med; 2000 Mar; 27(3):351-7. PubMed ID: 10774890
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of technetium-99m-ethylenedicysteine in renal disorders and determination of extraction ratio.
Kabasakal L; Atay S; Vural VA; Ozker K; Sönmezoglu K; Demir M; Uslu I; Işitman AT; Onsel C
J Nucl Med; 1995 Aug; 36(8):1398-403. PubMed ID: 7629584
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m L,L-ethylenedicysteine clearance and correlation with iodine-125 orthoiodohippurate for the determination of effective renal plasma flow.
Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Besse T; Squifflet JP; Beckers C
Eur J Nucl Med; 1996 Apr; 23(4):365-70. PubMed ID: 8612654
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous technetium-99 MAG(3), iodine-131-orthoiodohippurate and iodine-125 iothalamate clearance and biodistribution after bolus injection in rats.
Casadevall G; Turull A; Piera C; Queralt J
Biopharm Drug Dispos; 2000 Jul; 21(5):181-92. PubMed ID: 11180197
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
Taylor AT; Lipowska M; Hansen L; Malveaux E; Marzilli LG
J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
[TBL] [Abstract][Full Text] [Related]
11. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
Coveney JR; Robbins MS
J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
[TBL] [Abstract][Full Text] [Related]
12. Comparison of technetium-99m-ll-EC isomers in rats and humans.
Taylor A; Hansen L; Eshima D; Malveaux E; Folks R; Shattuck L; Lipowska M; Marzilli LG
J Nucl Med; 1997 May; 38(5):821-6. PubMed ID: 9170454
[TBL] [Abstract][Full Text] [Related]
13. 99mTc(CO)3-nitrilotriacetic acid: a new renal radiopharmaceutical showing pharmacokinetic properties in rats comparable to those of 131I-OIH.
Lipowska M; Marzilli LG; Taylor AT
J Nucl Med; 2009 Mar; 50(3):454-60. PubMed ID: 19223406
[TBL] [Abstract][Full Text] [Related]
14. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.
Rehling M; Nielsen BV; Pedersen EB; Nielsen LE; Hansen HE; Bacher T
Eur J Nucl Med; 1995 Dec; 22(12):1379-84. PubMed ID: 8586082
[TBL] [Abstract][Full Text] [Related]
15. 99mTc(CO)3(NTA) and 131I-OIH: comparable plasma clearances in patients with chronic kidney disease.
Taylor AT; Lipowska M; Cai H
J Nucl Med; 2013 Apr; 54(4):578-84. PubMed ID: 23424193
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
Ozker K; Onsel C; Kabasakal L; Sayman HB; Uslu I; Bozluolçay S; Cansiz T; Kapicioğlu T; Urgancioğlu I
J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m DTPA dimethyl ester: a renal function imaging agent. Comparative studies in animals with technetium-99m mercaptoacetyl triglycine and 131I-ortho-iodohippurate.
Bhowal K; Bhattacharyya S; Majumdar A; Giri C; Vanaja R; Ramamoorthy N; Ganguly S; Sarkar BR; Banerjee S; Chatterjee Debnath M
Nucl Med Commun; 2003 May; 24(5):583-95. PubMed ID: 12717078
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m-L,L-ethylenedicysteine scintigraphy in patients with renal disorders.
Gupta NK; Bomanji JB; Waddington W; Lui D; Costa DC; Verbruggen AM; Ell PJ
Eur J Nucl Med; 1995 Jul; 22(7):617-24. PubMed ID: 7498222
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics of 99mTc-MAG3 and 131I-OIH: comparative study based on 2 compartment model analysis].
Shuke N; Takashio T; Sato J; Ishikawa Y; Saito Y; Yamamoto W; Aburano T; Mizunaga M; Kaneko S; Yachiku S; Ogawa Y; Kikuchi K; Sasajima T; Kubo Y
Kaku Igaku; 1996 May; 33(5):513-20. PubMed ID: 8699619
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 99Tcm-bicisate as a renal imaging agent.
Ozker K; Kabasakal L; Liu Y; Hellman RS; Isitman A; Krasnow AZ; Collier BD
Nucl Med Commun; 1997 Aug; 18(8):771-5. PubMed ID: 9293508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
